Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients
Clinical trial NCT05062525 · COMPLETED
Trial details
- NCT number
- NCT05062525
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-28
- Primary completion
- 2021-09-28
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.